Top Abstract Purchase Related
Home
>
Node
>
Subnode

The benefits of daily hemofiltration in the management of anuria in patients with severe heart failure (NYHA IV)

Iorio, L.; Simonelli, R.; Nacca, R.G.; Saltarelli, G.; Violi, F.

International Journal of Artificial Organs 21(8): 457-459

1998

ISSN/ISBN: 0391-3988
PMID: 9803347
Document Number: 488953
The aim of the study was to evaluate the daily use of hemofiltration in patients with anuria and heart failure IV NYHA, and not reacting to pharmacological therapy. Patients were submitted to daily hemofiltration therapy considering: the dry weight, BP, pO2, creatininemia, natriemia, kaliemia, and magnesiemia. Every month an echocardiogram and an ECG were done. Two patients passed from IV to III class NYHA, with a reduction in the telediastolic diameter and improvement in the ejection fraction and in the cardiothoracic index. In NYHA IV patients, it was possible to obtain a very good improvement in the clinical situation, echocardiographic parameters and survival with daily hemofiltration.

Document emailed within 1 workday
Secure & encrypted payments

Arutiunov, G.P.; Kostiukevich, O.I.; Rylova, N.V.; Voevodina, N.I.; Korsunskaia, M.I. 2003: Effect of enteral feeding on exercise tolerance and clinical picture in patients with NYHA class III-IV chronic heart failure Kardiologiia 43(5): 52-55
Violi, F.; Nacca, R.G.; Iengo, G.; Iorio, L. 2009: Long-term sustained low efficiency dialysis in eight patients with class IV NYHA heart failure resistant to high-dose diuretic treatment Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 26(Suppl 46): 50-52
Kanoksilp, A.; Hengrussamee, K.; Wuthiwaropas, P. 2009: A comparison of one-year outcome in adult patients with heart failure in two medical setting: heart failure clinic and daily physician practice Journal of the Medical Association of Thailand 92(4): 466-470
Varani, E.; Casella, G.; Magnani, G.; Prati, F.; Magelli, C.; Magnani, B. 1990: The clinical evaluation of the severity of chronic heart failure: a comparison between the NYHA functional class and the Goldman scale Cardiologia 35(8): 651-656
Hallauer, W.; Kern, M.; Busse, J. 1987: Pheochromocytoma with anuria, heart failure and malignant arrhythmias Medizinische Klinik 82(24): 882-884
Cipolla, C.M.; Rimondini, A.; Della Bella, P.; Fabbiocchi, F.; Grazi, S.; Marenzi, G.; Sganzerla, P.; Tondo, C.; Sisillo, E.; Susini, G. 1987: Acute treatment of refractory congestive heart failure using hemofiltration Cardiologia 32(1): 69-72
Tanabe, T. 1998: Impaired heart rate variability in patients with symptomatic NYHA class II-IIi hypertrophic cardiomyopathy Rinsho Byori. Japanese Journal of Clinical Pathology 46(10): 1030-1036
Tienhaara, A.; Pelliniemi, T.T. 1990: Megaloblastic anemia in patients with severe congestive heart failure Duodecim; Laaketieteellinen Aikakauskirja 106(17): 1219-1222
Gadzhiev, N.G.; Gadzhiev, G.G.; Samedov, R.I. 1992: Experience in the treatment of patients with severe heart failure using isolated ultrafiltration Kardiologiia 32(9-10): 111-112
Ageev, F.T.; Gerasimova, V.V.; Mareev, V.Iu.; Barsov, D.A.; Sergeev, I.L.; Belenkov, I.N. 1992: Use of functional classes to assess the status of patients with severe heart failure Kardiologiia 32(2): 48-53
Ludka, O.; Spinar, J.; Pozdísek, Z.; Musil, V.; Spinarová, L.; Vítovec, J.; Tomandl, J. 2010: Is there circadian variation of big endothelin and NT-proBNP in patients with severe congestive heart failure? Vnitrni Lekarstvi 56(6): 488-493
Lenz, K.; Kranz, A.; Kramer, L.; Buder, R.; Schollmayer, E. 1996: Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure Wiener Klinische Wochenschrift 108(16): 505-509
Ahmed, A. 2009: DEFEAT - Heart Failure: a guide to management of geriatric heart failure by generalist physicians Minerva Medica 100(1): 39-50
Takane, H.; Nakamoto, H.; Arima, H.; Shoda, J.; Moriwaki, K.; Ikeda, N.; Kobayashi, K.; Kanno, Y.; Sugahara, S.; Okada, H.; Suzuki, H. 2006: Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 141-146
Dargie, H.J.; Cleland, J.G.; Leckie, B.J.; Inglis, C.G.; East, B.W.; Ford, I. 1987: Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure Circulation 75(5 Part 2): Iv98
Ferrari, V.; Sher, D.; Marchetti, G. 1986: A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure Arzneimittel-Forschung 36(2a): 398-405
He, L.-x.; Sun, L.-l.; Yang, Y.-j.; Zhang, J.; Zhang, Y.-h.; Song, W.-h.; Huang, Y.; Lü, R.; Ji, S.-m. 2012: Clinical experience of supplying sodium chloride for the treatment of patients with severe heart failure Zhonghua Xin Xue Guan Bing Za Zhi 40(9): 766-769
Bulava, A.; Lukl, J.; Hutyra, M.; Marek, D. 2007: Long term results of cardiac resynchronisation therapy for patients with severe heart failure Vnitrni Lekarstvi 53(11): 1153-1163
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Lambertz, H.; Erbel, R.; Meyer, J.; Schweizer, P.; Effert, S. 1982: Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure Zeitschrift für Kardiologie 71(2): 65-74